Related Experiment Video
Updated: Jan 3, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
Determinants of linear growth faltering among children with moderate-to-severe diarrhea in the Global Enteric
Rebecca L Brander1, Patricia B Pavlinac2, Judd L Walson3
1Department of Epidemiology, University of Washington, Seattle, WA, USA. rbrander@uw.edu.
Insights
Moderate-to-severe diarrhea (MSD) in young children can stunt growth. Factors like young age and malnutrition predict growth faltering, enabling early intervention for at-risk infants and toddlers.
Area of Science:
- Pediatric Gastroenterology
- Global Child Health
- Nutritional Epidemiology
Background:
- Moderate-to-severe diarrhea (MSD) in children under two years old is a significant risk factor for impaired linear growth.
- Identifying children at high risk for growth faltering after MSD is crucial for timely intervention.
Purpose of the Study:
- To identify clinical and sociodemographic risk factors for linear growth faltering in children with MSD.
- To develop a clinical prediction tool for identifying children most vulnerable to growth deterioration post-MSD.
Main Methods:
- Log-binomial and linear regression analyses were performed on data from the Global Enteric Multicenter Study (GEMS) involving 5902 children (0-23 months) with MSD in Africa and Asia.
- A prediction model was developed using backward elimination and Akaike Information Criterion, incorporating factors like age, malnutrition, and clinical signs.
Main Results:
- Severe linear growth faltering (loss of ≥0.5 length-for-age z-score) occurred in 24.2% of children over 50-90 days follow-up.
- Younger age (0-12 months), acute malnutrition, non-dysenteric diarrhea, poor sanitation, and IMCI danger signs were associated with growth decline.
- A prediction model including age, wasting, stunting, fever, and danger signs achieved an AUC of 0.67.
Conclusions:
- Younger age, acute malnutrition, MSD severity, and sociodemographic factors significantly impact short-term linear growth after diarrhea.
- Routine data collected during MSD episodes can effectively identify children at risk for growth deterioration, guiding targeted interventions.
Background:
Moderate-to-severe diarrhea (MSD) in the first 2 years of life can impair linear growth. We sought to determine risk factors for linear growth faltering and to build a clinical prediction tool to identify children most likely to experience growth faltering following an episode of MSD.
Methods:
Using data from the Global Enteric Multicenter Study of children 0-23 months old presenting with MSD in Africa and Asia, we performed log-binomial regression to determine clinical and sociodemographic factors associated with severe linear growth faltering (loss of ≥ 0.5 length-for-age z-score [LAZ]). Linear regression was used to estimate associations with ΔLAZ. A clinical prediction tool was developed using backward elimination of potential variables, and Akaike Information Criterion to select the best fit model.
Results:
Of the 5902 included children, mean age was 10 months and 43.2% were female. Over the 50-90-day follow-up period, 24.2% of children had severe linear growth faltering and the mean ΔLAZ over follow-up was - 0.17 (standard deviation [SD] 0.54). After adjustment for age, baseline LAZ, and site, several factors were associated with decline in LAZ: young age, acute malnutrition, hospitalization at presentation, non-dysenteric diarrhea, unimproved sanitation, lower wealth, fever, co-morbidity, or an IMCI danger sign. Compared to children 12-23 months old, those 0-6 months were more likely to experience severe linear growth faltering (adjusted prevalence ratio [aPR] 1.97 [95% CI 1.70, 2.28]), as were children 6-12 months of age (aPR 1.72 [95% CI 1.51, 1.95]). A prediction model that included age, wasting, stunting, presentation with fever, and presentation with an IMCI danger sign had an area under the ROC (AUC) of 0.67 (95% CI 0.64, 0.69). Risk scores ranged from 0 to 37, and a cut-off of 21 maximized sensitivity (60.7%) and specificity (63.5%).
Conclusion:
Younger age, acute malnutrition, MSD severity, and sociodemographic factors were associated with short-term linear growth deterioration following MSD. Data routinely obtained at MSD may be useful to predict children at risk for growth deterioration who would benefit from interventions.
More Related Videos
08:23Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: